Curtiss-Wright (NYSE: CW) director Larry Wyche receives $160,000 stock award

Rhea-AI Filing Summary

Curtiss-Wright Corporation director Larry D. Wyche reported an equity grant of restricted common stock. On February 4, 2026, he acquired 128 shares of common stock at a reference price of $624.93 per share under the company’s 2024 Omnibus Incentive Plan.

The award represents half of a $160,000 annual restricted stock grant for non-employee directors, with the number of shares determined by dividing the grant value by the closing price and rounding down. Wyche elected to defer receipt of the remaining 128 shares to a later date. Following this transaction, he beneficially owned 1,514 common shares directly. Restrictions on the granted shares generally lapse after one year or earlier upon death, disability, or failure to be reelected.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wyche Larry D

(Last) (First) (Middle)

C/O CURTISS-WRIGHT CORPORATION

130 HARBOUR PLACE DRIVE

(Street)

DAVIDSON NC 28036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CURTISS WRIGHT CORP [ CW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/04/2026		A(1)		128(2)	A	$624.93(3)	1,514	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares were issued pursuant to the Company's 2024 Omnibus Incentive Plan in which non-employee directors receive an annual grant of restricted stock for service on the board. The restrictions on these shares lapse upon the shorter of (a) one year from the date of grant or (b) until such time as the service of the recipient as a non-employee Director of the Company shall have ended by reason of his or her (i) death or disability or (ii) failure to be reelected.

2. The number of shares is arrived by dividing the closing price of the Issuer's securities on February 4, 2026 into $160,000, the amount of the stock award granted to the Issuer's non-employee directors. The number of shares is rounded down to the nearest whole share. This amount reflects 50% of the reporting person's annual restricted stock award. The reporting person has elected to defer receipt of the remaining 50% (i.e., 128 shares) of his annual restricted stock award to a later date.

3. Price is based on the close price for the Registrant's common stock on February 4, 2026, the date the reporting person earned the annual award.

Remarks:

	George P. McDonald By Power of Attorney for Larry D. Wyche	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Curtiss-Wright (CW) director Larry D. Wyche report on this Form 4?

Larry D. Wyche reported receiving 128 shares of Curtiss-Wright common stock as a restricted stock grant. The award was issued under the 2024 Omnibus Incentive Plan as part of his annual compensation for board service as a non-employee director.

How was the Curtiss-Wright (CW) stock grant for Larry D. Wyche calculated?

The grant was based on a $160,000 annual stock award for non-employee directors. The company divided $160,000 by the February 4, 2026 closing price of $624.93, rounding down to determine the number of restricted shares issued as part of the grant.

How many Curtiss-Wright (CW) shares did Larry D. Wyche receive and defer?

Wyche received 128 restricted shares immediately and elected to defer another 128 shares to a later date. Together, these represent 50% issued now and 50% deferred of his annual restricted stock award for service as a non-employee director.

What are the vesting conditions on Larry D. Wyche’s Curtiss-Wright (CW) restricted stock?

The restrictions on the shares lapse on the earlier of one year from the grant date or when Wyche’s service as a non-employee director ends due to death, disability, or failure to be reelected, aligning vesting with continued or terminated board service.

How many Curtiss-Wright (CW) shares does Larry D. Wyche own after this transaction?

After the reported grant, Wyche beneficially owns 1,514 shares of Curtiss-Wright common stock directly. This total reflects his holdings immediately following the February 4, 2026 restricted stock issuance reported in the Form 4 filing.

Is this Curtiss-Wright (CW) Form 4 transaction a market purchase or sale?

The transaction is an acquisition of restricted stock granted as compensation, not an open-market purchase or sale. Shares were issued under the 2024 Omnibus Incentive Plan based on the company’s closing stock price on February 4, 2026.